BLK
47
3
PDCO
77
3
AEP
45
5
MCD
52
3
CLX
65
2
PBI
30
-8
SBUX
29
-2
CTAS
36
8
TAP
57
6
M
40
3
HBAN
47
7
MAS
46
3
GT
43
2
LH
33
3
IRM
33
5
BMY
40
-5
AXP
63
3
VIX
41
-11
RF
44
10
DHI
36
3
BLK
47
3
PDCO
77
3
AEP
45
5
MCD
52
3
CLX
65
2
PBI
30
-8
SBUX
29
-2
CTAS
36
8
TAP
57
6
M
40
3
HBAN
47
7
MAS
46
3
GT
43
2
LH
33
3
IRM
33
5
BMY
40
-5
AXP
63
3
VIX
41
-11
RF
44
10
DHI
36
3
Financhill
Back

Regional Health Properties Vs. Novo Nordisk AS Industry Stock Comparison

Sell
32

RHE
Regional Health Properties

Last Price:
$1.47
Seasonality Move:
19.6%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Sell
32
Regional Health Properties (RHE) is a Sell

Is Regional Health Properties a Buy, Sell or Hold?

  • The current Regional Health Properties [RHE] share price is $1.51. The Score for RHE is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • RHE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RHE Stock Price Chart

What is Regional Health Properties's stock price today?

  • The Regional Health Properties share price today is $1.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RHE is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

RHE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 41.19 Sell
Chaikin Money Flow: 7577 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.5 - 1.7) Sell
Bollinger Bands (100): (1.62 - 1.98) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

RHE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.53 Sell
20-day SMA: 1.62 Sell
50-day SMA: 1.69 Sell
200-day SMA: 2.14 Sell
8-day EMA: 1.54 Sell
20-day EMA: 1.59 Sell
50-day EMA: 1.68 Sell
200-day EMA: 2.01 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

Regional Health Properties Earnings Growth & RHE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.66 per share.

Regional Health Properties Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):